Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Superfiliate Reviews & Ratings
    49 Ratings
    Company Website
  • Revaly Reviews & Ratings
    7 Ratings
    Company Website
  • AthenaHQ Reviews & Ratings
    50 Ratings
    Company Website
  • optivalue.ai Reviews & Ratings
    4 Ratings
    Company Website
  • Checksum.ai Reviews & Ratings
    2 Ratings
    Company Website
  • wp2print Reviews & Ratings
    7,748 Ratings
    Company Website
  • Pipedrive Reviews & Ratings
    12,537 Ratings
    Company Website
  • HubSpot AEO Reviews & Ratings
    151 Ratings
    Company Website
  • Dynamo Software Reviews & Ratings
    71 Ratings
    Company Website
  • SciSure Reviews & Ratings
    311 Ratings
    Company Website

What is Iktos?

Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.

What is Genedata Biologics?

Genedata Biologics® significantly advances the creation of biotherapeutics such as bispecifics, ADCs, TCRs, CAR-Ts, and AAVs, offering an all-encompassing solution for the sector. Esteemed as a premier platform in its domain, it seamlessly integrates all discovery processes, empowering researchers to focus on true innovation. By employing a cutting-edge system specifically designed to digitize the biotherapeutic discovery journey, research timelines can be notably expedited. This platform streamlines complex R&D activities by aiding in the design, tracking, testing, and evaluation of new biotherapeutic entities. It accommodates a variety of formats, including antibodies, bi- or multi-specifics, ADCs, novel scaffolds, and therapeutic proteins, along with engineered therapeutic cell lines like TCRs and CAR-T cells. As a fully integrated data backbone, Genedata Biologics links all R&D activities, from library design and immunization to selection and panning, molecular biology, screening, protein engineering, expression, purification, and analytics, resulting in thorough evaluations of candidate developability and manufacturability. This comprehensive integration not only enables researchers to make well-informed choices but also fosters a culture of exploration and advancement in biotherapeutic innovation. Ultimately, the synergy of these capabilities positions Genedata Biologics as a vital asset in the competitive landscape of biopharmaceutical development.

Media

Media

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

Integrations Supported

API Availability

Has API

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS
On-Prem

Supported Platforms

SaaS

Customer Service / Support

Standard Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
On-Site Training

Training Options

Webinars

Company Facts

Organization Name

Iktos

Company Location

France

Company Website

iktos.ai/makya/

Company Facts

Organization Name

Genedata

Date Founded

1997

Company Location

Switzerland

Company Website

www.genedata.com/products-services/biologics

Categories and Features

Drug Discovery

Not specified

Categories and Features

Drug Discovery

Not specified

Life Sciences

Not specified

Popular Alternatives

AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA

Popular Alternatives

BIOVIA Discovery Studio Reviews & Ratings

BIOVIA Discovery Studio

Dassault Systèmes
SILCS Reviews & Ratings

SILCS

SilcsBio
3decision Reviews & Ratings

3decision

Discngine
ESMC Reviews & Ratings

ESMC

Biohub